101 related articles for article (PubMed ID: 17768302)
21. Myocardial glucose transport and utilization: a target for therapeutic intervention.
Singh PP; Lago RM; Nesto RW
Rev Cardiovasc Med; 2008; 9(2):106-10. PubMed ID: 18660731
[TBL] [Abstract][Full Text] [Related]
22. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
Stratmann B; Tschoepe D
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
[TBL] [Abstract][Full Text] [Related]
23. Structural brain imaging in diabetes: a methodological perspective.
Jongen C; Biessels GJ
Eur J Pharmacol; 2008 May; 585(1):208-18. PubMed ID: 18407264
[TBL] [Abstract][Full Text] [Related]
24. [Proatherogenic lipid metabolism disturbances in impaired glucose tolerance].
Okopień B; Stachura-Kułach A; Kułach A; Krysiak R; Herman ZS
Pol Merkur Lekarski; 2005 Feb; 18(104):219-22. PubMed ID: 17877135
[TBL] [Abstract][Full Text] [Related]
25. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
26. Glucolipotoxicity and the heart.
Toth PP; Raghavan VA
Heart Fail Clin; 2012 Oct; 8(4):xvii-xviii. PubMed ID: 22999250
[No Abstract] [Full Text] [Related]
27. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning.
Maack C; Dabew ER; Hohl M; Schäfers HJ; Böhm M
Circ Res; 2009 Oct; 105(8):811-7. PubMed ID: 19729596
[TBL] [Abstract][Full Text] [Related]
28. Intramural pathology in the diabetic heart: interstitial and microvascular alterations.
Factor SM
Mt Sinai J Med; 1982; 49(3):208-14. PubMed ID: 6981760
[No Abstract] [Full Text] [Related]
29. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
Franjic B; Marwick TH
J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
[TBL] [Abstract][Full Text] [Related]
30. Disturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db mice.
Yamamoto T; Watabe K; Nakahara M; Ogiyama H; Kiyohara T; Tsutsui S; Tamura S; Shinomura Y; Hayashi N
J Gastroenterol Hepatol; 2008 Apr; 23(4):660-7. PubMed ID: 18341539
[TBL] [Abstract][Full Text] [Related]
31. In-hospital stay of patient with acute coronary syndrome with or without diabetes mellitus.
Novo G; Scordato F; Cerruto G; Vitale G; Ciaramitaro G; Coppola G; Farinella M; Rotolo A; Indovina G; Assennato P; Novo S
Minerva Cardioangiol; 2009 Apr; 57(2):159-64. PubMed ID: 19274026
[TBL] [Abstract][Full Text] [Related]
32. Liver lipid metabolism.
Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
[TBL] [Abstract][Full Text] [Related]
34. Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
Lee LM; Chang CK; Cheng KC; Kou DH; Liu IM; Cheng JT
Neurosci Lett; 2008 Aug; 441(2):201-4. PubMed ID: 18603373
[TBL] [Abstract][Full Text] [Related]
35. The effects of maternal dietary treatments with natural PPAR ligands on lipid metabolism in fetuses from control and diabetic rats.
Capobianco E; Martínez N; Higa R; White V; Jawerbaum A
Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):191-9. PubMed ID: 18947987
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle.
Bugianesi E
Hepatology; 2008 Jan; 47(1):2-4. PubMed ID: 18161723
[No Abstract] [Full Text] [Related]
37. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
[TBL] [Abstract][Full Text] [Related]
38. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.
Wang Y; Ebermann L; Sterner-Kock A; Wika S; Schultheiss HP; Dörner A; Walther T
Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756
[TBL] [Abstract][Full Text] [Related]
39. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
[TBL] [Abstract][Full Text] [Related]
40. Ischemic preconditioning phosphorylates mitogen-activated kinases and heat shock protein 27 in the diabetic rat heart.
Ebel D; Toma O; Appler S; Baumann K; Frässdorf J; Preckel B; Rösen P; Schlack W; Weber NC
Horm Metab Res; 2009 Jan; 41(1):10-5. PubMed ID: 18810710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
